NUP98 and precursor B-cell acute lymphoblastic leukemia: KO of HoxBlinc in 961C or A1929 B-ALL cells carrying NUP98-PHF23 fusion led to significantly inhibited cell proliferation, as determined by cell viability counts and Ki67 staining assays (Figure 3, D and E, and Supplemental Figure 3F).